Please use this identifier to cite or link to this item:
Title: Substance use, socio-demographic characteristics, and self-rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort study
Authors: Black, Emma;Bruno, Raimondo;Mammen, Kristie;Mills, Llewellyn;Siefried, Krista J;Deacon, Rachel M;Shakeshaft, Anthony;Dunlop, Adrian J;Ezard, Nadine;Montebello, Mark;Childs, Steven ;Reid, David;Holmes, Jennifer;Lintzeris, Nicholas
Affliation: Central Coast Local Health District
Issue Date: 14-Jul-2023
Source: Online ahead of print
Journal title: The Medical journal of Australia
Department: Drug & Alcohol
Abstract: To investigate the demographic characteristics, substance use, and self-rated health of people entering treatment in New South Wales public health services for alcohol, amphetamine-type stimulants, cannabis, cocaine, or opioids use, by principal drug of concern. Baseline findings of a cohort study; analysis of data in patient electronic medical records and NSW minimum data set for drug and alcohol treatment services. People completing initial Australian Treatment Outcomes Profile (ATOP) assessments on entry to publicly funded alcohol and other drug treatment services in six NSW local health districts/networks, 1 July 2016 - 30 June 2019. Socio-demographic characteristics, and substance use and self-rated health (psychological, physical, quality of life) during preceding 28 days, by principal drug of concern. Of 14 087 people included in our analysis, the principal drug of concern was alcohol for 6051 people (43%), opioids for 3158 (22%), amphetamine-type stimulants for 2534 (18%), cannabis for 2098 (15%), and cocaine for 246 (2%). Most people commencing treatment were male (9373, 66.5%), aged 20-39 years (7846, 50.4%), and were born in Australia (10 934, 86.7%). Polysubstance use was frequently reported, particularly by people for whom opioids or amphetamine-type stimulants were the principal drugs of concern. Large proportions used tobacco daily (53-82%, by principal drug of concern group) and reported poor psychological health (47-59%), poor physical health (32-44%), or poor quality of life (43-52%). The prevalence of social disadvantage and poor health is high among people seeking assistance with alcohol, amphetamine-type stimulants, cannabis, cocaine, or opioids use problems. Given the differences in these characteristics by principal drug of concern, health services should collect comprehensive patient information during assessment to facilitate more holistic, tailored, and person-centred care.
DOI: 10.5694/mja2.52039
Publicaton type: Journal Article
Keywords: Drug and Alcohol
Mental Health
Study or Trial: Cohort Study
Appears in Collections:Mental Health

Show full item record

Page view(s)

checked on Oct 2, 2023

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.